Pharmacy Barriers to Receiving Buprenorphine Among Patients Undergoing Telemedicine Addiction Treatment
In this cross-sectional study of patients receiving telemedicine treatment for opioid use disorder, challenges filling buprenorphine prescriptions were prevalent and led to concerning periods when patients were untreated and at an increased risk of returning to nonprescribed opioid use. There is a critical need for interventions to ensure sufficient access to buprenorphine, including implementing buprenorphine stocking requirements and medication delivery services through collaborating pharmacies.
Authors
- Lucas G. Hill (ORCID: https://orcid.org/0000-0001-5958-0159)
- Eileen Barrett (ORCID: https://orcid.org/0000-0002-9452-6155)
- Marlene C. Lira (ORCID: https://orcid.org/0000-0001-7967-1963)
- Maitreya Coffey (ORCID: https://orcid.org/0009-0004-6059-9710)
- Cynthia Jimes
- Lauren E. Hendy
- Amanda Olguin
Institutions
- Johns Hopkins University (US)
- University of Pittsburgh (US)
- Workit Health (US)
- Geisinger Commonwealth School of Medicine (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.27418
- Citations
- 2
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.76